View of A 3% topical gel formulation of tenofovir disoproxil fumarate (TDF) for the treatment of human immunodeficiency virus (HIV) by experimental approach

Return to Article Details A 3% topical gel formulation of tenofovir disoproxil fumarate (TDF) for the treatment of human immunodeficiency virus (HIV) by experimental approach Download Download PDF